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EFFECTS OF LOW CONCENTRATIONS OF ROTENONE UPON
MITOHORMESIS IN SH-SY5Y CELLS
Xiong Yuyun1, Qian Jinjun2*, Xu Minfang3, Qiu Jing3, Xia Juan3, Ma Rui1, Zhu Li4,
Gao Jing3*  1Department of Clinical Laboratory Diagnostics, School of Medical
Science and Laboratory Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013,
P.R. China; 2Department of Neurology, Fourth Affiliated Hospital, Jiangsu
University, Zhenjiang, Jiangsu 212001, P.R. China; 3Department of Medicinal
Pharmacy, School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R.
China; 4Department of Neurobiology and Neurochemistry, Institute for Nautical
Medicine and Jiangsu Key Laboratory of Neurogeneration, Nantong University,
Nantong 226001, P.R. China
 The mitochondrial toxin rotenone exerts cytotoxicity via overproduction of reactive
oxygen species (ROS) and depolarization of the mitochondrial membrane. We investigat-
ed the effects of rotenone (12.5, 25, 50, 100 nmol/L) on mitochondrial biogenesis and
the potential roles of ROS production in SH-SY5Y cells. Mitochondrial biogenesis was
assessed by counting the number of mitochondria, determining protein expression of per-
oxisome proliferator-activated receptor γ coactivator α (PGC1-α) and its regulator, SIRT1,
and oxygen consumption. ROS production and levels of reduced glutathione (GSH) and
oxidized glutathione(GSSG) were also determined. Compared with controls, rotenone
(12.5 nmol/L) significantly increased the quantity of mitochondria and amount of oxygen
consumption, whereas rotenone at >12.5 nmol/L decreased the quantity of mitochondria
and amount of oxygen consumption. GSH contents and GSH/GSSG were also signifi-
cantly enhanced by rotenone at 12.5 nmol/L and decreased by rotenone at >12.5 nmol/L.
Except for ROS production and SIRT1 protein expression, all concentration–response
relationships showed a typical inverted-U shape. ROS production was continually
increased in cells treated with rotenone. These data indicate that low concentrations of
rotenone can induce mitohormesis, which may be attributed to ROS production.
Key words: mitohormesis; rotenone; mitochondria; PGC1-α
1. INTRODUCTION
Rotenone is a highly toxic, naturally occurring botanical pesticide. It
was mainly used in organic farming and in the management of nuisance
fish (Hatcher et al., 2008). It is extremely hydrophobic and hence readily
crosses biologic membranes, apparently without a specific transport sys-
tem, and acts by inhibiting mitochondrial complex I (Esteve-Rudd et al.,
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2011). Thus, rotenone is recognized as a mitotoxin. However, Ichikawa
and colleagues found that pretreatment with low-level rotenone could
inhibit lipid peroxidation and alleviate the intestinal mucosal inflamma-
tion induced by ischemia–reperfusion in rats (Ichikawa et al., 2004). This
finding implied that, as a mitotoxin, rotenone may produce different cel-
lular effects at low levels from those at high levels. Hence, exploring the
potential underlying mechanisms of protection exerted by pretreatment
with rotenone is important.
Mitochondria are the major sites for energy production in cells.
When cells and tissues demand increased energy requirements, the pri-
mary response is to produce new mitochondria (Sano and Fukuda,
2008). In general, mitochondrial biogenesis is regulated by changing
energy requirements and physiological conditions. Recent evidence has
provided insight into the mechanisms underlying the interaction
between mitochondria-derived reactive oxygen species (ROS) signaling
and mitochondrial biogenesis (Piantadosi and Suliman, 2006; Piantadosi
et al., 2008). There is increasing evidence to suggest that ROS may be
‘double-edged swords’. That is, ROS overproduction is toxic to cells, but
they also play an important part in the cell signaling involved in the
antioxidant defense network. The polyunsaturated fatty acids in mem-
brane lipids are particularly vulnerable to ROS attack, and they undergo
peroxidation. These products of lipid peroxidation form protein adducts
and DNA adducts and have biphasic properties, i.e., high doses cause
overt toxicity whereas low doses interact with genetic signaling systems
that upregulate gene expression to counteract stressor challenges and re-
establish homeostasis (Sano and Fukuda, 2008). This adaptive stress-pro-
tective mechanism resulting from the induction of ROS-related stress
emanating from mitochondria has been defined as ‘mitochondrial
hormesis’ or ‘mitohormesis’ (Tapia, 2006).
Besides ROS, peroxisome proliferator-activated receptor γ coactivator
α (PGC1α) controls the biogenesis and function of mitochondria (Finck
and Kelly, 2006), and thereby plays an important part in brain-energy
homeostasis and neurodegenerative diseases (Cui LB et al., 2006; St-
Pierre et al., 2006). Furthermore, PGC1α activity was shown to be regu-
lated by Sirt1, a member of the silent information regulator 2 family of
proteins (sirtuins) (Lagouge et al., 2006; Nemoto et al., 2005). Sirtuins are
nicotinamide adenine dinucleotide (NAD)-dependent deacetylases regu-
lating mitochondria-involved survival and longevity (Grubisha et al.,
2005). However, data about rotenone-induced mitohormesis as well as
the potential roles of PGC1α and Sirt1 are lacking.
Evaluating the mitochondrial effects of low-level rotenone and the
potential underlying mechanisms are important because they may pro-
vide more evidence for risk assessment and aid in the discovery of new
agents for the prevention and treatment of neurodegenerative diseases.
Low doses of rotenone upon mitohormesis
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2. MATERIALS AND METHODS
2.1. Materials
Rotenone, antimycin and cccp were purchased from Sigma–Aldrich
(St. Louis, MO, USA). Minimum essential medium (MEM), Ham’s F-12
Nutrient Mixture (F12 medium), non-essential amino acids and trypsin
were obtained from Gibco BRL (Rockville, MD, USA). The fluorescent
probe MitoTracker Red FM was purchased from Molecular Probes
(Eugene, OR, USA). Fetal bovine serum (FBS) was obtained from
Sijiqing Biological Engineering Materials (Hangzhou, China). DCFH-DA
and lysis buffer were purchased from Biyotime (Nantong, China). β-actin
primary antibody was from Abcam (Cambridge, MA, USA). PGC-1α and
SIRT1 primary antibodies were from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). All secondary antibodies were from Boster Biological
Technology (Wuhan, China). All other reagents were from commercial
suppliers and of standard biochemical quality.
2.2. Culture of SH-SY5Y Cells
Human neuroblastoma SH-SY5Y cells (a gift from Dr. Zunji Ke,
Chinese Academy of Sciences, Beijing China) were maintained in
MEM/F12 medium, supplemented with 1% non-essential amino acids
(Gibco) and 10% FBS, 100 U/mL penicillin and 100 U/mL streptomycin
at 37°C in 5% CO2. Cells were subcultured once every 3 days. Before
experiments, SH-SY5Y cells were plated at ≈3×104 viable cells per well in
six-well plates. Cells were treated with rotenone for 48 h after seeding.
The choice of concentrations used (12.5–100 nmol/L) was based on our
previous experiments (Xiong et al., 2009). Rotenone was prepared by dis-
solving in dimethyl sulfoxide (DMSO). The final concentration of DMSO
was <0.1%, which was shown to have no toxic effect on the cells.
2.4. Mitochondrial mass
MitoTracker Red FM binds to lipids in mitochondrial membranes
regardless of the membrane potential or oxidant status of mitochondria.
Thus, fluorescence intensity was used to measure the number of mito-
chondria present (Pendergrass et al., 2004). To determine the numbers
of mitochondria, a suspension of cells in free serum medium was loaded
with 200 nmol/L MitoTracker Red FM for 30 min at 37°C. Measurements
of fluorescence intensity were made at an excitation wavelength of 581
nm and emission wavelength of 644 nm using a fluorescence spectrome-
ter (Molecular Devices Corporation, Sunnyvale, CA, USA). Amounts were
determined by comparing the intensity of the fluorescence signal pro-
duced by 1×104 cells.
X. Yuyun and others
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2.5. Reduced glutathione (GSH) content
The reduced GSH content and total glutathione /its oxidized form
(GSSG)in cells was determined using Ellman’s reagent, i.e., 5,5-dithiobis-
(2-nitrobenzoic acid) (Sedlak and Lindsay, 1968). Briefly, cells were lysed
using cell lysis buffer and lysates centrifuged at 12,000 × g at 4°C for 5
min. GSH content and total glutathione / GSSG in the supernatant was
then estimated using Ellman’s reagent. Spectrophotometric absorbance
was determined at 420 nm and 405 nm using a GSH or T-GSH/GSSG kit
(Nanjing Jiancheng Bioengineering Company, Nanjing, China). The
reduced GSH results were expressed as milligrams of GSH per milligram
of protein. To calculate the GSH/GSSG ratio, GSH (reduced form) was
obtained by subtracting the 2×GSSG values from the total glutathione val-
ues.
2.6. Oxygen consumption
SH-SY5Y cells were harvested and resuspended in MEM/F12 medi-
um. MEM/F12 medium was equilibrated at 37°C with atmospheric oxy-
gen. Oxygen consumption was measured with a Clark-type oxygen elec-
trode (Hansatech, King’s Lynn, UK) fitted in a 2 mL thermojacketed sam-
ple chamber (37°C) under constant stirring. Results were expressed as
nanomoles of O2 per minute per cell.
2.7 ROS levels
ROS levels were measured using the ROS-specific probe 5′,6′-
chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA;
Beyotime Institute of Biotechnology, Nantong, China). After diffusion
into cells, DCFDA is deacetylated by cellular esterases to a non-fluores-
cent compound, which is later oxidized by ROS into 2′,7′-dichlorofluo-
rescin (DCF). DCF is a highly fluorescent compound which can be detect-
ed by fluorescence spectroscopy with maximum excitation and emission
spectra of 488 nm and 525 nm, respectively. Cells in free serum medium
were loaded with freshly prepared 5 µmol/L H2DCFDA for 30 min and
washed thrice with phosphate-buffered saline (PBS). Fluorescence inten-
sity representing ROS levels of live cells was measured using a fluores-
cence spectrometer. Results were expressed as fluorescence intensity per
1×104 cells.
2.8. Western blot analyses
After treatment, 1×106 cells were collected and subjected to western
blot analyses. Cell proteins were extracted and quantified with a BCA
Protein Quantitative Analysis Kit (Beyotime Institute of Biotechnology).
After addition of sample loading buffer, protein samples underwent sodi-
Low doses of rotenone upon mitohormesis
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um dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with
8% gels, and were subsequently transferred to polyvinylidene fluoride
(PVDF) membranes (Bio-Rad, Hercules, CA, USA). Each membrane was
incubated in fresh blocking buffer (0.1% Tween 20 in Tris-buffered
saline, pH 7.4, containing 5% non-fat dried milk) at room temperature
for 30 min and then probed with anti-PGC-1α antibody, anti-Sirt1 anti-
body or anti-β-actin antibody in blocking buffer at 4°C overnight.
Membranes were washed thrice for 5-min each using PBST (PBS and
0.1% Tween 20). Membranes were then incubated with the appropriate
horseradish peroxidase (HRP)-conjugated secondary antibodies at room
temperature for 2 h. Immunoreactive proteins were visualized using the
chemiluminescent reagent ECL according to manufacturer instructions.
Quantity One software was used to quantify protein band intensities in
digital images of the blot.
2.9. Statistical analyses
Differences were tested by one-way analysis of variance (ANOVA) fol-
lowed by the Student–Newman–Keuls test as a post-hoc test. P<0.05 was
considered significant. All of the experiments were done in triplicate and
repeated three or four times.
3. RESULTS
3.1 Effects of rotenone on mitochondrial biogenesis
We first investigated the effects of rotenone on the number of mito-
chondria in SH-SY5Y cells using MitoTracker Red FM. Alterations in the
mitochondrial mass when SH-SY5Y cells were exposed to rotenone
(12.5–100 nmol/L) for 24 h are shown in Fig. 1. When rotenone (25
nmol/L) was exposed to cells, the mitochondrial mass increased signifi-
cantly (p<0.05) compared with that of controls. When the concentrations
of rotenone increased, the numbers of mitochondria decreased.
3.2 Effects of rotenone on mitochondrial respiration
Oxygen consumption is a critical readout of mitochondrial func-
tion(Gusdon et al., 2012). The CCCP induced maximal respiratory capac-
ity were increased in SH-SY5Y cells(Fig 2). Quantification of mitochondr-
ial respiration in SH-SY5Y cells treated with various concentrations of
rotenone is shown in Fig 2. In the concentration range 12.5–25 nmol/L,
the oxygen consumption of cells increased by 33.8–32.5% compared with
that in control cells (p<0.05). The increased oxygen consumption can be
attenuated by 20 µmol/L antimycin. This suggested that cellular mito-
chondrial metabolism was enhanced in response to low concentrations of
rotenone.
X. Yuyun and others
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3.3 Effects of rotenone on protein expressions of PGC-1α and SIRT1
To test whether the mitochondrial biogenesis and improvement in
mitochondrial function are closely related to mediated by SIRT1 and
PGC-1α, we next investigated rotenone impact on its expression.
Expression of PGC-1α and SIRT1 increased at low concentrations of
rotenone (12.5 and 25 nmol/L) (Fig. 3). SIRT1 demonstrated a ~ 20%
increase compared with control group, while PGC-1α showed ~26%
increase. However, at higher concentrations (50 and 100 nmol/L),
expression of SIRT1 still increased (~ 40% compared with control
group)but that of PGC-1α decreased to normal level.
3.5 Effects of rotenone on ROS production
To elucidate whether ROS can initiate mitohormesis, cells were treat-
ed with 12.5–100 nmol/L rotenone for 24 h, and then measured by the
fluorescent probe DCFH-DA, which is freely permeative to the cell mem-
brane. Low doses of rotenone led to an increase in ROS levels. Figure 4
shows that 12.5-100 nmol/L rotenone present a 20% - 43% increase in
ROS levels over control SH-SY5Y cells. ROS levels increased significantly
Low doses of rotenone upon mitohormesis
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FIG. 1. Rotenone stimulates mitochondria generation. Changes in the mitochondrial stimulation of
SH-SY5Y cells treated with rotenone at the indicated concentration for 24 h were analyzed by fluo-
rescence spectrometry. Data are means ± SD, n = 5. *P<0.05 vs. the control group. 
FIG. 2. Oxygen consumption in SH-SY5Y cells treated with rotenone. Quantification of the rate of
oxygen consumption of SH-SY5Y cells treated with rotenone or 10 µmol/L cccp for 24 h. Antimycin
induced oxygen consumption were measured by treatment with 20 µmol/L antimycin after detected
the basal. Data are means ± SD, n = 5. *P<0.05 vs. the control group. 
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compared with the control group(p<0.05), and ROS levels increased in a
dose-dependent manner.
3.4. Effects of rotenone on GSH contents
Oxidative stress is related to both an increase in ROS production and
a decrease in the antioxidant content. Compared with the control group,
GSH and GSH/GSSG ratio levels were significantly increased at a low
concentration of rotenone (12.5 nmol/L) which is of great relevance
with respect to oxidative stress, whereas higher levels of rotenone sup-
pressed GSH contents (Fig. 5).
4. DISCUSSION
The main finding of the present study was that low doses of rotenone
enhanced mitohormesis in SH-SY5Y cells via regulation of the interaction
between PGC1α and SIRT1. These results provide a bio-energetic basis
for the protection of rotenone preconditioning against lipid peroxida-
tion and intestinal mucosal inflammation induced by ischemia–reperfu-
sion in rats (Ichikawa et al., 2004). Combined with the mitohormesis pro-
duced by another mitotoxin and mitochondrial uncoupler, 2,4-dinitro-
X. Yuyun and others
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FIG. 3. Effects of rotenone on expression of PGC1α and SIRT1. (A) SH-SY5Y cells were incubated
with various concentrations of rotenone for 24 h. Levels of PGC1α and SIRT1 were detected by west-
ern blot. (B) Protein band intensities were normalized to β-actin. Data are means ± SD, n = 3. *P<0.05
vs. the control group. 
FIG. 4. ROS generation in SH-SY5Y cells after treatment with 12.5–100 nmol/L rotenone for 24 h.
Values are means ± SD (n = 3) of fluorescence intensity. Data represent means ± SD, n = 5. *P<0.05
vs. the control group. 
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phenol (Caldeira da Silva et al., 2008), we may imply that the mito-
hormesis of low-level mitotoxins may be a general phenomenon.
Mitohormesis is based on the assumption that an increase in mito-
chondrial activity and the subsequent increase in ROS production leads
to activation of the cellular defense system in response to low levels of
deprivation of metabolic substrates (Ristow and Zarse, 2010; Ristow and
Schmeisser, 2011; Schulz et al., 2007; Schwartz and Sack, 2008; Tapia,
2006). Mitotoxins such as 2,4-dinitrophenol have been found to induce
mitohormesis which can extend human lifespans by promoting:
enhanced rates of tissue respiration; increased levels of glucose, triglyc-
eride and insulin in serum; decreased levels of ROS; decreased oxidation
of DNA and protein in tissues; reduced body weight (Caldeira da Silva et
al., 2008).
We identified induction of mitohormesis by treatment of cells with a
low dose of rotenone (12.5 nmol/L) for 24 h, and oxygen consumption
was also enhanced. This stimulation of mitohormesis and oxygen con-
sumption was different to results in other studies, in which a decrease in
mitochondrial mass and respiration were observed (Koopman et al., 2006;
Yang et al., 2010). These differences might be due to different selected
dosages and treatment duration, which may activate or inactivate signal
pathways by regulating mitohormesis.
From the viewpoint of bio-energetics, PGC-1α appears to act as a ‘mas-
ter regulator’ by integrating and coordinating the activity of multiple
transcription factors such as nuclear respiratory factors (NRF-1, -2), per-
oxisome proliferator activated receptor-α (PPARα) and mitochondrial
transcription factor A (mtTFA) in mitohormesis and energy metabolism
(Puigserver et al., 1998). Moreover, PGC-1α was shown to mediate mito-
hormesis via cyclic guanosine monophosphate (cGMP)-mediated upreg-
ulation of transcriptional factors (Brown, 2007). Increases in cGMP levels
can lead to expression of the deacetylase SIRT1 (Nisoli et al., 2005).
SIRT1 is a NAD+-dependent deacetylase that can deacetylate PGC-1α and
Low doses of rotenone upon mitohormesis
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FIG. 5. Effects of rotenone on the activities of (A) GSH and (B) GSH /GSSG in SH-SY5Y cells.
Exponentially growing cells were treated with the indicated amount of rotenone for 24 h. *p<0.05 as
compared with the control group. Data are means ± SD, n = 5. *P<0.05 vs. the control group. 
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thereby increase its activity (Nisoli and Carruba, 2006). SIRT1 activation
by 3,5,4,9-trihydroxystilbene (resveratrol) has recently been implicated in
the mitohormesis induced by this polyphenol in cultures of liver and mus-
cle cells (Baur et al., 2006; Lagouge et al., 2006). It appears that SIRT1
functions as a signaling mediator that links mitochondrial activity and
transcriptional regulation at the nucleus, leading to the expression of
genes involved in mitohormesis through activation of PGC-1α. The pres-
ent study showed that rotenone activated PGC-1α and SIRT1 in different
manners. The former showed biphasic effects and the latter demonstrat-
ed monophasic effects, which may imply complex interactions between
PGC-1α and SIRT1 in mitohormesis. This finding was consistent with a
study that showed that higher overexpression of SIRT1 caused significant
mitochondrial abnormalities (i.e., abnormal morphology of mitochon-
dria and abnormal gene expression related to mitochondria) whereas
lower overexpression of SIRT1 showed the opposite effect (Kawashima et
al., 2011). Low overexpression of SIRT1 may induce mitohormesis via
deacetylate PGC-1α, but higher SIRT1 overexpression may induce hyper-
deacetylation of histone proteins and repress PGC-1α transcription,
which will subsequently decrease the mass and function of mitochondria.
Mitohormesis theory posits that ROS production by mitochondria
enhances stress resistance, thereby extending human lifespans (Schulz et
al., 2007). Deoxyglucose, which are capable of inducing mitochondrial
ROS formation can generate lifespan extension, whereas pretreatment of
cells with the antioxidant N-acetyl cysteine (NAC) was shown to signifi-
cantly reduce the induction of ROS and, in parallel, completely abolish
increases in stress resistance. These findings suggest that increased for-
mation of ROS is required for the hormetic induction of stress resistance.
Consistent with this hypothesis, the present study showed that a low dose
of rotenone (12.5 nmol/L) can increase ROS production, which will acti-
vate mitohormesis-mediated stress resistance through upregulation of
ROS defense enzymes. A mechanistic link between increased respiration,
elevated production of ROS, and adaptive induction of ROS defense sys-
tems has been suggested. ROS have been traditionally viewed as damage-
causing entities. However, they are equally important for normal cellular
functioning, and have been noted as mediators of cellular metabolism
(Cadenas, 2004). It is highly likely that increased ROS levels activate an
array of sensors and mediators, which in turn orchestrate the multi-
faceted response to mitohormesis, ultimately leading to promotion of cel-
lular homeostasis.
In total, the present study suggested that low concentrations of
rotenone may induce mitohormesis via upregulation of the production
and defense capacities of ROS. Moderate increases in ROS levels may
lead to increased expression of SIRT1, which then deacetylates PGC-1α,
and subsequently stimulates mitohormesis. If there is overproduction of
X. Yuyun and others
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ROS, high expression of SIRT1 may repress PGC-1α transcription, lead-
ing to damage to the mass and function of mitochondria. The present
study demonstrated that application of mitotoxins may be an alternative
intervention to maintain physiological and metabolic homeostasis, and to
prolong lifespans in mammals.
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